All,
What's the prevailing opinion on Corixa? I'm looking more and more at companies that work to boost the immune system in various ways and this one looks good but maybe a bit pricey. Then again, if they do well, todays price won't matter a whole lot.
Richard, I presume you noticed that they're working with SmithKline Beecham on a vaccine for RSV. It includes their adjuvant. What do you think of this in relation to ViroPharma? Hopefully you didn't work for them or any of the companies they've recently gobbled up as a consultant too :-)
Thanks, Torben
P.S. I liked their web page by the way. It was nicely done. Professional and helpful. To most of you, this is probably irrelevant, but I like to be able to jump to a company's web page and see a well organized one that's kept up to date. It also needs to contain facts, not hype. This one qualifies. Yes, it's probably a strange criterion, but when someone puts up a web page that's shoddy or doesn't have up to date information on it, I take that as a lack of regard for investors.
P.P.S. I read the Wall Street Transcript interview with their CEO. I liked the way he came across. Anyone else have thoughts on him? |
